Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
April 16, 2024 04:35 ET
|
Boehringer Ingelheim
Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV®Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8...
Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers
April 11, 2024 08:05 ET
|
Tevogen Bio Inc
Tevogen’s Chief Scientific Officer explains the company’s oncology pipeline strategy as it relates to harnessing Cytotoxic T Lymphocytes to target cancers.
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
April 09, 2024 16:00 ET
|
Mural Oncology, Inc.
Mural Oncology, a clinical-stage immuno-oncology company, shared pre-clinical data from its Interleukin-18 (IL-18) and IL-12 programs at AACR today.
Aegion Announces Acquisition of Toncco
March 27, 2024 11:00 ET
|
Aegion Corp
Aegion Corporation today announced the acquisition of Toncco, an underground utilities company based in Ogden, Utah.
Inter&Co Inc. Reports Record Profits, with R$352 Million in Net Income in 2023
February 07, 2024 16:47 ET
|
Inter&Co, Inc
BELO HORIZONTE, Brazil, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), the premier Financial Super App that provides financial and digital commerce services to more...
Inter&Co Secures Long-Term Naming Rights for Orlando’s Soccer-Specific Stadium
January 18, 2024 11:10 ET
|
Inter&Co, Inc
Financial Super App secures long-term naming rights; Home of Orlando City SC and Orlando Pride to be renamed Inter&Co StadiumFirst-of-its-kind international partnership will bring new investment...
Inter&Co Announces Commencement of Follow-on Public Offering of its Class A Common Shares
January 16, 2024 17:44 ET
|
Inter&Co, Inc
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- INTER & CO, INC. (NASDAQ: INTR; B3: INBR32) (“Inter&Co” or the “Company”) announced, on the date hereof, the commencement of a follow-on public...
Boehringer expands production site in Greece for new medicine
January 11, 2024 10:15 ET
|
Boehringer Ingelheim
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of EUR 120 million, the...
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
January 08, 2024 07:00 ET
|
Mural Oncology, Inc.
Strategic changes to ARTISTRY-6 and ARTISTRY-7, both potentially registrational trials of nemvaleukin, are intended to result in more clinically meaningful dataMural intends to nominate development...
Inter&Co presents new brand and consolidates position as financial Super App
December 20, 2023 08:10 ET
|
Inter&Co, Inc
BELO HORIZONTE, Brazil, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Inter&Co has a new brand to reflect the company's evolution. Three years after its last rebranding, the institution is unveiling a new...